Section Chief, Heart Failure/Transplant at Rutgers University. Professor of Medicine
New Brunswick, NJ
Joined September 2018
- Tweets472
- Following96
- Followers619
- Likes190
Pinned Tweet
@HoustonShockHSS @BurkhoffMd @CSWorkingGroup @JumeanMarwan @NirUrielMD @Nikhil15
Who agrees with me that in cardiogenic shock each subsequent SCAI stage should carry higher mortality? If yes -why SCAI B is higher than C? I called it the SCAI B mortality pardox- just presented at THT. All hypotheses are welcome!
Maya Guglin retweeted
Time for #CardiogenicShock guidelines?
Our @JACCJournals #JACCAdvances State-of-the-Art Review: Evolving evidence across CS phenotypes, hemodynamics & #MCS & where guidance needs to evolve.
👉 jacc.org/doi/10.1016/j.jacad…
Shaped by expertise & insights of an all 🌟 coauthor team
Maya Guglin retweeted
Revascularization of #CAD in HF : a #EJHF expert consensus statement
📍Only two RCTs have investigated the role of revascularization in HFrEF—#STICH (CABG vs medical therapy in HFrEF) and #REVIVED-BCIS-2 (PCI vs medical therapy in #HFrEF)
📍No RCTs have investigated revascularization in #HFpEF
📍Symptom derived Mx algorithms for HF patients with multivessel coronary disease warrant further validation.
academic.oup.com/eurjhf/adva…
@EJHFEiC @ESC_Journals
Revascularization of coronary artery disease in heart failure: a European Journal of Heart Failure expert consensus statement
#EJHF @ESC_Journals
academic.oup.com/eurjhf/adva…
@HanCardiomd @AmrAbdin10 @GiuseppeGalati_
Maya Guglin retweeted
2/. Our HF patients undergo therapies that are necessary for their care, such as heart transplant, heart assist devices, and other. During these procedures, heart tissue often has to be removed. Instead of allowing this precious tissue to be discarded, for years our patients have
Maya Guglin retweeted
1/. Our multi-year collaborative work with colleagues at UCSD & New York Genome Center was published in Science. This study presents specific targets for developing new therapies for heart failure (HF)!
healthcare.utah.edu/newsroom…
Maya Guglin retweeted
Infarct size is not reduced in patients with anterior #STEMI without shock if they receive a combination of a trans-valvular micro-axial flow pump plus delayed #PCI versus PCI alone, results from the STEMI-Door to Unload trial show. #ACC26 on #CRTonline ow.ly/VIXa50YAX5j
Out of hospital cardiac arrest in cardiogenic shock equals SCAI stage E, right? Perhaps… sharing my thoughts at THT.@CSWorkingGroup @BurkhoffMd @NirUrielMD @JumeanMarwan @Nikhil15 @MarkBelkinMD
In-hospital and out-of hospital cardiac arrest in cardiogenic shock- same or different? Proud to present at THT. @CSWorkingGroup @BurkhoffMd @JumeanMarwan @MarkBelkinMD @Nikhil15
HF2 is the group working on remote hemodynamic monitoring. Dr. Thomas Heywood, the founder and the soul of the group, presenting at THT.
Rutgers students and residents presenting scientific abstracts at THT! Proud of Paul Kaddissi and Sakeeb Khan!
Maya Guglin retweeted
Not all ICDs in patients with LVAD are futile! We recorded immediate drop in pulmonary pressures and increase in CVP in an LVAD patient who went into ventricular fibrillation, with immediate recovery post defibrillation. Check out our case report! digitalcommons.library.tmc.e…
Maya Guglin retweeted
The #CSWG was honored to recognize @BurkhoffMd with a Lifetime Achievement Award for his contributions to cardiovascular medicine, heart failure, cardiogenic shock, hemodynamics, and for his humility and mentorship. Thank you Marty Leon for the Keynote! @crfheart @hopkinsheart
Maya Guglin retweeted
This statement provides guidance on the role of static, provocative, and serial assessments of invasive hemodynamics in phenotyping and management of patients with heart failure, pulmonary hypertension, left ventricular assist support devices, and cardiogenic shock. Further research is needed to better understand how to individualize care in response to dynamic testing.
✍🏼 @MarkBelkinMD @FudimMarat @cla_baratto @JonGrinsteinMD @IanBHollis @rachkataria @GLewisCardiol @MakLab_ @RyanTedfordMD @JTThibs @JP_HFpEF
Maya Guglin retweeted
High-Granularity Machine Learning Prediction of Acute Brain Injury in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation
ASAIO Journal 71(12):p 1013-1022, December 2025. | DOI: 10.1097/MAT.0000000000002449
ow.ly/VHnq50XMGco
#ASAIO
ALT Variables investigated in the VA-ECMO patient population, including pre-ECMO and on-ECMO laboratory values, hemodynamic parameters, arterial blood gas measurements, and neurologic and clinical complications. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CVP, central venous pressure; HCO₃, bicarbonate; INR, international normalized ratio; MAP, mean arterial pressure; PaO₂, partial pressure of oxygen; PaCO₂, partial pressure of carbon dioxide; PP, pulse pressure; PT, prothrombin time; PTT, partial thromboplastin time; rSO₂, regional cerebral oxygen saturation; SaO₂, arterial oxygen saturation; SBP, systolic blood pressure; SpO₂, peripheral oxygen saturation; SvO₂, mixed venous oxygen saturation; VA-ECMO, venoarterial extracorporeal membrane oxygenation.
Congratulations to our Heart Failure fellow Marcos Molina who mached to the Cardiology fellowship at Rutgers! And yes, we are looking for applicants to our non-ACGME accredited Advanced HF fellowship. If interested, please send you CV to [email protected]. We'll teach you how to care for patients with HF, cardiogenic shock, post-LVAD, and heart transplant. We are in New Brunswick, NJ.
Who agrees with me?
There is a dire shortage of doctors signing up to heart failure fellowships with >60% programs unfilled. I propose the following:
- allow the entry into HF training to general internists—including those who did not match to cardiology
- if they then proceed to cardiology fellowship, allow them to sit for HF Boards after they are Board certified in Cardiology
- If they remain internists with HF training, create an alternative certificate for them.
This would yield immediate benefits:
- all available fellowship slots would be filled with eager and capable trainees
- teaching faculty will be teaching again
- the market will be saturated with HF doctors
Read my whole piece pubmed.ncbi.nlm.nih.gov/4123…
@HFSA @JACCJournals @nikhilna @NirUrielMD @Aheartdoc @AHAScience @EMDeFilippisMD @DmitryAbramovMD @EiranGorodeski
